130 related articles for article (PubMed ID: 12366716)
1. Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes.
Yasukawa M; Yamauchi H; Azuma T; Takada K; Ishimura M; Fujita S
Eur J Haematol; 2002 Aug; 69(2):112-4. PubMed ID: 12366716
[TBL] [Abstract][Full Text] [Related]
2. Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes.
Bolam S; Orchard J; Oscier D
Br J Haematol; 1997 Oct; 99(1):158-61. PubMed ID: 9359516
[TBL] [Abstract][Full Text] [Related]
3. Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update.
Lefrère F; Lévy V; François S; Delarue R; Ifrah N; Tilly H; Valensi F; Troussard X; Varet B; Hermine O
Leukemia; 2004 Nov; 18(11):1924-5. PubMed ID: 15385943
[No Abstract] [Full Text] [Related]
4. Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes.
Lefrère F; Hermine O; Belanger C; François S; Tilly H; Lebas de La Cour JC; Valensi F; Varet B; Troussard X
Leukemia; 2000 Apr; 14(4):573-5. PubMed ID: 10764141
[TBL] [Abstract][Full Text] [Related]
5. Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders.
Johnson SA; Owen RG; Oscier DG; Leblond V; Levy V; Jaeger U; Seymour JF
Clin Lymphoma; 2005 Mar; 5(4):294-7. PubMed ID: 15794869
[TBL] [Abstract][Full Text] [Related]
6. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Thieblemont C; Felman P; Berger F; Dumontet C; Arnaud P; Hequet O; Arcache J; Callet-Bauchu E; Salles G; Coiffier B
Clin Lymphoma; 2002 Jun; 3(1):41-7. PubMed ID: 12141954
[TBL] [Abstract][Full Text] [Related]
7. Severe T-mediated bone marrow aplasia in a patient with splenic lymphoma with villous lymphocytes (SLVL) previously treated with fludarabine regimen.
Rocco S; Improta S; Sagristani M; Quirino AA; Nitrato Izzo G; Russolillo S; Polistina MT; Mastrullo L
Haematologica; 2004 Jun; 89(6 Suppl):ECR19. PubMed ID: 15194555
[No Abstract] [Full Text] [Related]
8. Splenic lymphoma with villous lymphocytes: dissociated response with fludarabin.
Tchiknavorian X; Otto J; Pivot X; Arnaud MC; Schneider M; Thyss A
Hematol Cell Ther; 1999 Nov; 41(5):233-4. PubMed ID: 10651125
[No Abstract] [Full Text] [Related]
9. Blastic transformation of splenic lymphoma with villous lymphocytes after a well-controlled chronic phase of more than 10 years.
Kuwayama M; Machii T; Yamaguchi M; Yamaguti K; Kitani T; Kanakura Y
Int J Hematol; 2000 Feb; 71(2):167-71. PubMed ID: 10745627
[TBL] [Abstract][Full Text] [Related]
10. Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes.
Lefrère F; Hermine O; François S; Panelatti G; Valensi F; Grosbois B; Misset JL; Varet B; Troussard X
Leuk Lymphoma; 2000 Dec; 40(1-2):113-7. PubMed ID: 11426611
[TBL] [Abstract][Full Text] [Related]
11. Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes.
Troussard X; Cornet E
Curr Treat Options Oncol; 2007 Apr; 8(2):97-108. PubMed ID: 17634839
[TBL] [Abstract][Full Text] [Related]
12. Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hématologie Cellulaire (GFHC).
Troussard X; Valensi F; Duchayne E; Garand R; Felman P; Tulliez M; Henry-Amar M; Bryon PA; Flandrin G
Br J Haematol; 1996 Jun; 93(3):731-6. PubMed ID: 8652403
[TBL] [Abstract][Full Text] [Related]
13. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma.
Catovsky D; Matutes E
Semin Hematol; 1999 Apr; 36(2):148-54. PubMed ID: 10319383
[TBL] [Abstract][Full Text] [Related]
14. [Splenic lymphoma with villous lymphocytes. A clinical case].
Brambilla Pisoni G; Montalbetti L; Paparella P; Neri G
Minerva Med; 1997; 88(7-8):311-6. PubMed ID: 9304075
[TBL] [Abstract][Full Text] [Related]
15. Multiple M components in two patients with splenic lymphoma with villous lymphocytes.
Colović N; Miljić P; Colović M; Milosević-Jovcić N
Ann Hematol; 2006 Jan; 85(1):51-4. PubMed ID: 16007426
[TBL] [Abstract][Full Text] [Related]
16. Splenic lymphoma with villous lymphocytes.
Gupta R; Naseem S; Sukumaran S; Kashyap R; Kaur S; Paul L
Indian J Pathol Microbiol; 2008; 51(1):113-5. PubMed ID: 18417879
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of latent Epstein Barr virus infection induces remission of splenic lymphoma with villous lymphocytes.
Hansson M; Linde A; Olsson I
Int J Hematol; 2005 Jun; 81(5):413-6. PubMed ID: 16158822
[TBL] [Abstract][Full Text] [Related]
18. Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients.
Parry-Jones N; Matutes E; Gruszka-Westwood AM; Swansbury GJ; Wotherspoon AC; Catovsky D
Br J Haematol; 2003 Mar; 120(5):759-64. PubMed ID: 12614206
[TBL] [Abstract][Full Text] [Related]
19. Leukemic meningitis in a patient with splenic lymphoma with villous lymphocytes (SLVL). Meningitis as a possible initial manifestation of SLVL.
Yamazaki K; Shimizu S; Negami T; Sawada K; Nanasawa H; Ohta M; Konda S; Okuda K
Cancer; 1994 Jul; 74(1):61-5. PubMed ID: 8004584
[TBL] [Abstract][Full Text] [Related]
20. The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH.
Gruszka-Westwood AM; Matutes E; Coignet LJ; Wotherspoon A; Catovsky D
Br J Haematol; 1999 Mar; 104(3):600-4. PubMed ID: 10086800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
